Herpes zoster – typical and atypical presentations

References

• Galetta KM, Gilden D. Zeroing in on zoster: a tale of many disorders produced by one virus. J Neurol Sci. 2015;358:38–45. PubMed PMID: 26454371; PubMed Central PMCID: PMCPMC4628852. DOI:10.1016/j.jns.2015.10.004.
   PubMed Web of Science ®Google Scholar
• Volpi A. Severe complications of herpes zoster. Herpes. 2007;14 Suppl 2:35–39. PubMed PMID: 17939894.
   PubMedGoogle Scholar
• Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361–381. PubMed PMID: 8809466; PubMed Central PMCID: PMCPMC172899.
   PubMed Web of Science ®Google Scholar
• Johnson RW, Rice AS. Clinical practice postherpetic neuralgia. N Engl J Med. 2014;371:1526–1533. PubMed PMID: 25317872. DOI:10.1056/NEJMcp1403062.
   PubMed Web of Science ®Google Scholar
• Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369:255–263. PubMed PMID: 23863052. DOI:10.1056/NEJMcp1302674.
   PubMed Web of Science ®Google Scholar
• Takao Y, Miyazaki Y, Okeda M, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25:617–625. PubMed PMID: 26399445; PubMed Central PMCID: PMCPMC4626391. DOI:10.2188/jea.JE20140210.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. PubMed PMID: 24916088; PubMed Central PMCID: PMCPMC4067812. DOI:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Goldman GS, King PG. Review of the United States universal varicella vaccination program: herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine. 2013;31:1680–1694. PubMed PMID: 22659447; PubMed Central PMCID: PMCPMC3759842. DOI:10.1016/j.vaccine.2012.05.050.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Joesoef MR, et al. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159:739–745. PubMed PMID: 24297190. DOI:10.7326/0003-4819-159-11-201312030-00006.
   PubMed Web of Science ®Google Scholar
• Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis. 2008;197 Suppl 2:S58–S60. PubMed PMID: 18419410. DOI:10.1086/522123.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44 Suppl 1:S1–S26. PubMed PMID: 17143845. DOI:10.1086/510206.
   PubMed Web of Science ®Google Scholar
• Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186 Suppl 1:S91–S98. PubMed PMID: 12353193. DOI:10.1086/342963.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP, Wollan P, et al. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63:221–226. PubMed PMID: 27161774; PubMed Central PMCID: PMCPMC4928389. DOI:10.1093/cid/ciw296.
   PubMed Web of Science ®Google Scholar
• Chen S-Y, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42:325–334. PubMed PMID: 24214127; PubMed Central PMCID: PMCPMC3968442. DOI:10.1007/s15010-013-0550-8.
   PubMed Web of Science ®Google Scholar
• Borkar DS, Tham VM, Esterberg E, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology. 2013;120:451–456.
   PubMed Web of Science ®Google Scholar
• Kim CH, Choi H, Shin JE. Characteristics of hearing loss in patients with herpes zoster oticus. Medicine (Baltimore). 2016;95:e5438. PubMed PMID: 27861389; PubMed Central PMCID: PMCPMC5120946. DOI:10.1097/MD.0000000000005438.
   PubMed Web of Science ®Google Scholar
• Powell DR 2nd, Patel S, Franco-Paredes C. Varicella-zoster virus vasculopathy: the growing association between herpes zoster and strokes. Am J Med Sci. 2015;350:243–245. PubMed PMID: 25211583. DOI:10.1097/MAJ.0000000000000327.
   PubMed Web of Science ®Google Scholar
• Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss. 2012;20:441–451. PubMed PMID: 22822293; PubMed Central PMCID: PMCPMC3397124. DOI:10.1007/s10389-011-0481-8.
   PubMedGoogle Scholar
• Drolet M, Brisson M, Schmader K, et al. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain. 2010;11:1211–1221. PubMed PMID: 20434957. DOI:10.1016/j.jpain.2010.02.020.
   PubMed Web of Science ®Google Scholar
• Halling GC, Grose C. Focal herpes zoster encephalitis without a rash: diagnostic confusion between astrogliosis and low-grade glioma. Expert Rev Anti Infect Ther. 2016;14:1109–1111. PubMed PMID: 27748148; PubMed Central PMCID: PMCPMC5177966. DOI:10.1080/14787210.2016.1248944.
   PubMed Web of Science ®Google Scholar
• Kennedy PG. Zoster sine herpete: it would be rash to ignore it [Comment Editorial]. Neurol. 2011;76:416–417. PubMed PMID: 21282588. DOI:10.1212/WNL.0b013e31820a0d5d.
   PubMed Web of Science ®Google Scholar
• Blumenthal DT, Shacham-Shmueli E, Bokstein F, et al. Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF [Case Reports Research Support, N.I.H., Extramural]. Neurol. 2011;76:484–485. PubMed PMID: 21282595; PubMed Central PMCID: PMC3034410. DOI:10.1212/WNL.0b013e31820a0d28.
   PubMed Web of Science ®Google Scholar
• Gilden DH, Wright RR, Schneck SA, et al. Zoster sine herpete, a clinical variant [Case Reports Research Support, U.S. Gov’t, P.H.S. Review]. Ann Neurol. 1994;35:530–533. PubMed PMID: 8179298. DOI:10.1002/ana.410350505.
   PubMed Web of Science ®Google Scholar
• Epstein E, Jacobson HP. Bilateral Herpes Zoster complicating cutaneous, osseous and pulmonary tuberculosis. Arch Derm Syphilol. 1936;34(6):989–996. DOI:10.1001/archderm.1936.01470180056006.
   Google Scholar
• Leung AK, Barankin B. Bilateral symmetrical herpes zoster in an immunocompetent 15-year-old adolescent boy. Case Rep Pediatr. 2015;2015:121549. PubMed PMID: 25692062; PubMed Central PMCID: PMCPMC4323070. DOI:10.1155/2015/121549.
   PubMedGoogle Scholar
• Kantaria SM. Bilateral asymmetrical herpes zoster. Indian Dermatol Online J. 2015;6:236. PubMed PMID: 26009733; PubMed Central PMCID: PMCPMC4439767. DOI:10.4103/2229-5178.156448.
   PubMedGoogle Scholar
• Mobley CA. A case of asymmetrical, bilateral Herpes Zoster. JAMA. 1912;LIX(11):879. DOI:10.1001/jama.1912.04270090123022.
   Google Scholar
• Jacob FM. Bilateral herpes zoster following acute arsenic poisoning. Arch Derm Syphilol. 1931;24:280–282.
   Google Scholar
• Rattner H. Bilateral herpes zoster. Arch Derm Syphilol. 1938;38:436–437.
   Google Scholar
• Vijay A, Dalela G. Herpes zoster duplex bilateralis in immuno-competent patients: report of two cases. J Clin Diagn Res. 2015;9:WR01–3. PubMed PMID: 26816979; PubMed Central PMCID: PMCPMC4717711. DOI:10.7860/JCDR/2015/15728.6957.
   PubMedGoogle Scholar
• Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22:341–347. PubMed PMID: 8838194.
   PubMed Web of Science ®Google Scholar
• McDonald EM, De Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther. 2012;17:255–264. PubMed PMID: 22300753. DOI:10.3851/IMP2011.
   PubMed Web of Science ®Google Scholar
• Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain. 2015;28:177–184. PubMed PMID: 26175877; PubMed Central PMCID: PMCPMC4500781. DOI:10.3344/kjp.2015.28.3.177.
   PubMedGoogle Scholar
• Jackson JL, Gibbons R, Meyer G, et al. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med. 1997;157:909–912. PubMed PMID: 9129551.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen N, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009;(2):CD006866. PubMed PMID: 19370655. DOI:10.1002/14651858.CD006866.pub2.
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–2284. PubMed PMID: 15930418. DOI:10.1056/NEJMoa051016.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of Herpes Zoster. Recommendations of the advisory committee on immunization practices (ACIP). Mmwr. 2008;57:1–30.
   PubMedGoogle Scholar
• Schmader KE, Levin MJ, Gnann JW Jr., et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54:922–928. PubMed PMID: 22291101; PubMed Central PMCID: PMCPMC4542655. DOI:10.1093/cid/cir970.
   PubMed Web of Science ®Google Scholar
• Wyman MJ, Stabi KL. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Ann Pharmacother. 2013;47:1064–1068. PubMed PMID: 23715069. DOI:10.1345/aph.1R742.
   PubMed Web of Science ®Google Scholar
• Mills R, Tyring SK, Levin MJ, et al. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Vaccine. 2010 Jun 07;28(25): 4204–4209. PubMed PMID: 20416263. DOI:10.1016/j.vaccine.2010.04.003.
   PubMed Web of Science ®Google Scholar
• Weinberg A, Zhang JH, Oxman MN, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009;200:1068–1077. PubMed PMID: 19712037; PubMed Central PMCID: PMCPMC4014851. DOI:10.1086/605611.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Harpaz R, Luo Y, et al. Declining effectiveness of herpes zoster vaccine in adults aged >/=60 years. J Infect Dis. 2016;213:1872–1875. PubMed PMID: 26908728. DOI:10.1093/infdis/jiw047.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019–1032. PubMed PMID: 27626517. DOI:10.1056/NEJMoa1603800.
   PubMed Web of Science ®Google Scholar
• Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087–2096. PubMed PMID: 25916341. DOI:10.1056/NEJMoa1501184.
   PubMed Web of Science ®Google Scholar